CAY10593 inhibits the human P2X7 receptor independently of phospholipase D1 stimulation
A Pupovac1, L Stokes, R Sluyter
1School of Biological Sciences, University of Wollongong, Wollongong, NSW, Australia.
Abstract:
The P2X7 receptor is a trimeric ATP-gated cation channel important in health and disease. We have observed that the specific phospholipase D (PLD)1 antagonist, CAY10593 impairs P2X7-induced shedding of the 'low affinity' IgE receptor, CD23. The current study investigated the mode of action of this compound on P2X7 activation. Measurements of ATP-induced ethidium(+) uptake revealed that CAY10593 impaired P2X7-induced pore formation in human RPMI 8226 B cells, P2X7-transfected HEK-293 cells and peripheral blood mononuclear cells. Concentration response curves demonstrated that CAY10593 impaired P2X7-induced pore formation in RPMI 8226 cells more potently than the PLD2 antagonist CAY10594 and the non-specific PLD antagonist halopemide. Electrophysiology measurements demonstrated that CAY10593 also inhibited P2X7-induced inward currents. Notably, RT-PCR demonstrated that PLD1 was absent in RPMI 8226 cells, while choline-Cl medium or 1-butanol, which block PLD stimulation and signalling respectively did not impair P2X7 activation in these cells. This data indicates that CAY10593 impairs human P2X7 independently of PLD1 stimulation and highlights the importance of ensuring that compounds used in signalling studies downstream of P2X7 activation do not affect the receptor itself.
Insights
The P2X7 receptor antagonist CAY10593 inhibits ATP-induced pore formation, independent of phospholipase D1 (PLD1). This finding is crucial for understanding P2X7 receptor signaling and drug development.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- The P2X7 receptor is a critical ATP-gated ion channel involved in numerous physiological and pathological processes.
- Previous studies indicated that the phospholipase D1 (PLD1) antagonist CAY10593 affects P2X7 receptor-mediated CD23 shedding.
Purpose of the Study:
- To elucidate the mechanism of action of CAY10593 on P2X7 receptor activation.
- To determine if CAY10593's effects on P2X7 are mediated through PLD1 inhibition.
Main Methods:
- ATP-induced ethidium(+) uptake assays were performed in various cell types (RPMI 8226, HEK-293, PBMCs).
- Concentration-response curves were generated for CAY10593, CAY10594, and halopemide.
- Electrophysiology was used to measure P2X7-induced currents.
- RT-PCR was employed to assess PLD1 expression.
Main Results:
- CAY10593 significantly impaired P2X7-induced pore formation and inward currents in human cells.
- The inhibitory effect of CAY10593 on P2X7 was more potent than other PLD antagonists.
- PLD1 was found to be absent in RPMI 8226 cells, and PLD inhibition did not affect P2X7 activation.
Conclusions:
- CAY10593 inhibits human P2X7 receptor function independently of PLD1.
- This study underscores the necessity of validating that signaling modulators do not directly impact the target receptor, such as P2X7.
- Findings provide critical insights into P2X7 receptor pharmacology and potential off-target effects of antagonists.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Two...
GPCR Desensitization
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Desensitization and Tachyphylaxis
Several...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
G-Protein Gated Ion Channels
Sensory organs,...

